| Financial Year |
March 31 2023 |
| Monetary Funds |
340,649,084.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,639.10 |
| Accounts Receivable |
353,370,875.83 |
| Advances to Suppliers |
36,181,122.86 |
| Other Receivables |
20,062,768.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
296,570,119.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,713,367.83 |
| Total Current Assets |
1,057,596,978.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,945,488.24 |
| Investment Properties |
-- |
| Fixed Assetes |
693,478,227.65 |
| Under-construction Projects |
414,533,087.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,610,268.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,717,002.66 |
| Deferred Income Tax Assets |
3,458,763.83 |
| Other Non-Current Assets |
33,672,059.36 |
| Sub-Total of Non-Current Assets |
1,366,615,587.23 |
| Total Assets |
2,424,212,566.11 |
| Short-Term Loans |
640,516,582.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
173,847,200.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,922,203.79 |
| Taxes Payable |
8,451,803.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,112,985.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,600,101.61 |
| Other Current Liabilities |
162,775.55 |
| Sub-Total of Current Liabilities |
879,797,341.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,611,368.24 |
| Total Liabilities |
914,408,709.67 |
| Paid-In Capital(Or Share Stock) |
102,676,000.00 |
| Capital Surplus |
718,983,227.93 |
| Surplus Reserve |
49,704,972.57 |
| LESS:Treasury Stock |
39,998,889.92 |
| Undistributed Profits |
673,250,787.72 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,509,803,856.44 |
| Owner's Equity（Stockholder's Equity） |
1,509,803,856.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,424,212,566.11 |
